These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 12296634)
21. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
25. Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up. Martinez R; Bravo G; Burzaco J; Rey G Stereotact Funct Neurosurg; 1998 Oct; 70 Suppl 1():110-8. PubMed ID: 9782242 [TBL] [Abstract][Full Text] [Related]
26. Gamma knife radiosurgery for growth hormone-secreting pituitary adenomas invading the cavernous sinus. Fukuoka S; Ito T; Takanashi M; Hojo A; Nakamura H Stereotact Funct Neurosurg; 2001; 76(3-4):213-7. PubMed ID: 12378100 [TBL] [Abstract][Full Text] [Related]
27. Gamma Knife radiosurgery for functioning pituitary microadenoma. Kim MS; Lee SI; Sim JH Stereotact Funct Neurosurg; 1999; 72 Suppl 1():119-24. PubMed ID: 10681699 [TBL] [Abstract][Full Text] [Related]
35. Gamma Knife radiosurgery as a primary surgical treatment for hypersecreting pituitary adenomas. Zhang N; Pan L; Dai J; Wang B; Wang E; Zhang W; Cai P Stereotact Funct Neurosurg; 2000; 75(2-3):123-8. PubMed ID: 11740180 [TBL] [Abstract][Full Text] [Related]
36. Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. Sheehan JP; Niranjan A; Sheehan JM; Jane JA; Laws ER; Kondziolka D; Flickinger J; Landolt AM; Loeffler JS; Lunsford LD J Neurosurg; 2005 Apr; 102(4):678-91. PubMed ID: 15871511 [TBL] [Abstract][Full Text] [Related]